Ian Copple – Biomarker discovery to enable the non-invasive monitoring of NRF2 activator therapies in humans

Ian Copple – University of Liverpool – Medicines Discovery Catapult – Healthcare

Biomarker discovery to enable the non-invasive monitoring of NRF2 activator therapies in humans

The RiR Sprint scheme is now closed. Thank you for your interest.

Close Welcome Bar